Type
Reshoring
Country
France
Reshoring from
Portugal
Reshored business function
Production
Region
Location of affected unit(s)
Sector
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72.1 - Research And Experimental Development On Natural Sciences And Engineering

20 jobs
Number of planned job creations
Job creation
Announcement Date
21 March 2021
Employment effect (start)
21 March 2021
Foreseen end date
31 December 2023

Description

Affilogic, is a biotherapy company based in Nantes that in 2020 relocated the production of nanofitin molecules, previously outsourced to Portugal.

Nanofitins are protein molecules with properties similar to antibodies but 20 times smaller and 10 times more resistant. Affilogic received 25 million euro State aid to fortify its focus on developing nanofitins and facilitate the relocation of production. Through this operation, the company, which employed 29 people, aimed to transition from research to producing drug prototypes and managing the entire process in-house. The establishment of a new production unit, with an investment close to 5 million euros, was set to consolidate the company's activities, contributing to job creation, with the workforce projected to reach nearly 50 employees by the end of 2023.


Sources

Citation

Eurofound (2021), Affilogic, Reshoring in France, factsheet number 279, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/279.